MarketPulse

antibody therapy

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Immutrin Bolsters Leadership With Cardiovascular Expert as CMO, Launches US Operations

Biotech firm Immutrin appoints Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary to advance amyloidosis antibody therapy toward clinical trials.
MRKEWTXclinical developmentcardiovascular
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Rezolute to Present Rare Disease Pipeline at Citizens Life Sciences Conference

Rezolute to present ersodetug antibody therapy program at Citizens Life Sciences Conference in Miami, March 10-11, 2026, with direct investor meetings.
RZLTclinical trialsinvestor conference